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Abstract Musculoskeletal disorders often have associated
pain, functional impairment and work disability, and, not
surprisingly, are the most common reasons for utilizing
healthcare resources. Rheumatoid arthritis (RA) and fibro-
myalgia (FM) are causes of musculoskeletal pain and
disability. Research indicates that there is a widespread
impact of RA and FM on physical, psychological and social
factors in affected individuals, and thus, outcome measures
that encompass multiple aspects of quality of life are
needed. Generic measures of quality of life identify
associations between physical conditions and mental health
and highlight the need to address psychological functioning
to ultimately improve the individuals’ quality of life.
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Musculoskeletal disorders often have associated pain,
functional impairment and work disability, and, not
surprisingly, are the most common reasons for utilizing
healthcare resources [1, 2]. Rheumatoid arthritis (RA) and
fibromyalgia (FM) are among the most common causes of
musculoskeletal pain and disability. They are estimated in
community studies to affect 0.5–1a n d2 –6% of the
population, respectively [3–5]. These two conditions differ
in a number of ways: In particular, RA has a clear
pathophysiology with a range of clinical measures being
able to indicate its presence, whereas the biological basis
for FM is less defined with no “gold standard” test
available. Despite this difference, these two rheumatic
conditions share a range of associated outcomes. These
include not only pain and fatigue but also difficulties with
activities of daily living, ranging from basic and interme-
diate functions through to more complex tasks such as paid
employment and social roles, e.g. child rearing [2, 6].
Further, RA and FM are associated with poor psychological
functioning with 20 to 60% reporting depressive symptoms
[7–9]. It is clear that there is a widespread impact of RA
and FM on physical, psychological and social factors in
affected individuals, and thus, outcome measures that
encompass multiple aspects of quality of life are needed.
In this volume, Birtane et al. [10] study the use of a
generic measure of physical and psychological functioning in
patients with RA and FM and thus provide insights on the
quality of life outcomes in these disorders. Generic and self-
report measures of quality of life provide a wealth of
information regarding the experience of individuals with
rheumaticconditionsthatmedicalandobservationalmeasures
cannot capture [11]. One such measure is the Medical
Outcomes Survey 36 Items (SF-36) [12], which is a self-
report multidimensional measure of quality of life that has
been used extensively in RA and FM research [13, 14]. The
SF-36 includes subscales across eight dimensions of health
and well-being, including physical functioning, role physi-
cal, role emotional, bodily pain, general health, vitality,
social functioning and mental health. Scores for all subscales
are expressed on a scale of 0 to 100, with a higher score
indicating a better state of health. It has good reliability and
validity for both clinical and healthy community-based
samples [15].
A generic measure of quality of life can offer a number
of insights into the impact of rheumatic conditions on
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for interesting comparisons of the quality of life between
healthy individuals and those with rheumatic conditions
and other chronic physical conditions. Studies indicate that
those with RA and FM, almost invariably, have reduced or
compromised quality of life compared to healthy age-
matched controls. Both RA and FM have a similar impact
on psychological and physical functioning and social roles
as other chronic conditions that contribute to the global
burden of diseases, such as heart disease, chronic obstruc-
tive pulmonary disease and diabetes [10, 16, 17]. These
findings have implications on health policy and allocation
of funding for both healthcare and research. For instance,
musculoskeletal conditions affect more than 17% of the
community and 60% of working-aged adults, with projec-
tions indicating that arthritis will affect up to 20% of people
by 2020 [18]. The prevalence, cost and burden of
musculoskeletal disorders indicate that policymakers need
to address the impact on economies, healthcare systems and
society at large. For instance, if a public health intervention
in 2005 enabled the onset of arthritis to be delayed by
10 years, the age-related incidence rates would be reduced
by 11.1% before 2020 [18]. The burden of musculoskeletal
disorders and issues of impaired quality of life have become
an international health priority with initiatives such as the
Bone and Joint Decade launched by the World Health
Organization (WHO).
Birtane’s use of a generic measure of quality of life
highlights the fact that FM, a condition with unclear
pathophysiology, is associated with impaired quality of life
to a similar extent as RA. This is in keeping with the recent
models of quality of life or disability that place less
emphasis on disease processes, pathophysiology and/or
structural damage. Previous models of outcomes for
rheumatic conditions have a strong biomedical focus with
many models of disability or quality of life having an
implicit assumption that there is a linear relationship
between disease processes and disability. Attempting to
use such models of disability by reading from left to right
has obvious shortcomings because there are many instances
such as FM that do not have a fully identifiable disease
process [19]. Indeed, focusing on pathophysiology and
functional ability in a limited context without consideration
of the individual’s everyday tasks and roles sheds little light
on the quality of life [20].
Newer approaches to examining disability acknowledge
the roles of demographic, physiological, psychological,
social and environmental factors acting as buffers and
exacerbators of poor outcomes for chronic physical con-
ditions [2]. The International Classification of Functioning
(ICF) promoted by the WHO incorporates a broader
biopsychosocial framework of disability, health and
health-related states [21]. Indeed, the ICF takes a neutral
stand with regard to aetiology and allows researchers to
arrive at causal inferences using appropriate scientific
methods. The ICF attempts to dislodge assumptions that
the body level dysfunctioning, classified as impairments, is
the fundamental dimension of disability and quality of life
[21–23]. In other words, the quality of life in both RA and
FM is not contingent on aetiology. The presence of a
disability implies a cause, but the cause may not be
sufficient to explain the resulting quality of life [21, 24,
25]. Measures such as the SF-36 provide the building
blocks to create models of quality of life and study the
different perspectives of this process across a range of
chronic physical conditions as well as healthy individuals.
Within this framework, using generic measures of quality
of life can offer opportunities to frame research and
interventions that appropriately target the quality of life of
individuals with musculoskeletal disorders.
Using this approach, Birtane et al. [10] identified in
patients with RA and FM that the incidence of poor
physical and psychological functioning is almost invariably
greater than for healthy controls. Additionally, higher
depression levels are evident in patients with FM compared
to those with RA. It is not surprising that FM is associated
with the worst psychological functioning, given that
depression is often evident in individuals with FM [26].
These observations are consistent with previous findings,
which indicate that significant depressive symptoms are
reported by up to 60% of individuals with chronic physical
conditions. Addressing poor psychological functioning,
especially depression, in musculoskeletal conditions is
critical due to its impact on the condition itself. Reciprocal
relationships can occur between depression and pain and
disability leading to a cycle of poor mental and physical
health. Depression is related to poor treatment compliance
and increased morbidity and mortality in rheumatic con-
ditions [27]. Measures such as the SF-36 clearly identify
the associations between chronic physical conditions and
mental health and further highlight the importance of
addressing psychological functioning in both research and
interventions to ultimately improve the individuals’ quality
of life.
RA and FM are of course not mutually exclusive. The
pathophysiology of each disorder is different, and many
patients with RA also have FM, as do many other patients
with a variety of chronic rheumatic diseases. The substrate
of FM lies in the pain system, which can be functionally
activated by distress, a common feature of chronic painful
and disabling disorders. How much of the FM mechanism
contributes to the low quality of life of RA? Further
exploration of the mechanisms causing FM, with its
resultant highly significant effect on the quality of life, will
have a great impact on the management of not only FM
itself but also RA and related musculoskeletal conditions.
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